Dr. Richard Aplenc received his medical degree from the University of Virginia School of Medicine. He completed his internship and residency in pediatrics at the University of California at San Diego and his fellowship in pediatric hematology/oncology at Children's Hospital of Philadelphia (CHOP), University of Pennsylvania School of Medicine. In addition, he received a PhD in epidemiology from the University of Pennsylvania. Dr. Aplenc is a Professor of Pediatrics in the Department of Pediatrics and a core faculty member of the Center for Pediatric Clinical Effectiveness at CHOP. He holds the Mai and Harry F. West Endowed Chair in Pediatric Research. In addition, he is Professor of Epidemiology in Biostatistics and Epidemiology at the University of Pennsylvania School of Medicine.

Dr Aplenc is American Board of Pediatrics certified in hematology-oncology. He is Chief Clinical Research Officer at CHOP, and is an editorial reviewer for numerous peer-reviewed journals. Dr. Aplenc’s research focuses on improving the outcomes of children with cancer, particularly acute myeloid leukemia (AML). His work involves the treatment of AML in children and the use of genetic data to predict treatment response to therapeutic interventions.